Dose Escalation For INtraprostatic LEsions
Dose Escalation For INtraprostatic LEsions
Recruiting · NCT05851547 · Registry updated 2024-01-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose Escalation For INtraprostatic LEsions | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2024-01-05 | NCT05851547 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Knight Therapeutics (USA) Inc | 1 |
| Ottawa Hospital Research Institute | 121 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Ottawa Hospital Cancer Centre | Ottawa | Canada | 26 |